Total Payments
$74,541
2023 Payments
$5,652
Companies
19
Transactions
312
Medicare Patients
207
Medicare Billing
$35,422
Payment Breakdown by Category
Other$58,398 (78.3%)
Food & Beverage$7,251 (9.7%)
Travel$5,397 (7.2%)
Consulting$3,443 (4.6%)
Education$53.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,398 | 35 | 78.3% |
| Food and Beverage | $7,251 | 235 | 9.7% |
| Travel and Lodging | $5,397 | 38 | 7.2% |
| Consulting Fee | $3,443 | 2 | 4.6% |
| Education | $53.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $25,274 | 115 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $21,783 | 51 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $7,504 | 31 | $0 (2019) |
| IDORSIA PHARMACEUTICALS US INC | $5,652 | 3 | $0 (2023) |
| Allergan Inc. | $5,392 | 53 | $0 (2018) |
| Ironshore Pharmaceuticals Inc. | $5,341 | 20 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $3,043 | 6 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $164.63 | 10 | $0 (2018) |
| Neos Therapeutics, LP | $74.20 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $67.32 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $5,652 | 3 | IDORSIA PHARMACEUTICALS US INC ($5,652) |
| 2021 | $3,090 | 7 | Supernus Pharmaceuticals, Inc. ($3,043) |
| 2020 | $737.29 | 3 | Sunovion Pharmaceuticals Inc. ($737.29) |
| 2019 | $14,994 | 51 | Otsuka America Pharmaceutical, Inc. ($7,309) |
| 2018 | $29,055 | 132 | Teva Pharmaceuticals USA, Inc. ($14,314) |
| 2017 | $21,013 | 116 | Sunovion Pharmaceuticals Inc. ($12,092) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $36.48 | General |
| Category: INSOMNIA | ||||||
| 03/14/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $5.50 | General |
| Category: INSOMNIA | ||||||
| 03/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: INSOMNIA | ||||||
| 10/25/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 10/25/2021 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $47.70 | General |
| 05/17/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 05/17/2021 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $47.67 | General |
| 04/27/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 04/27/2021 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $47.70 | General |
| 02/24/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CNS | ||||||
| 04/22/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: CNS | ||||||
| 01/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CNS | ||||||
| 12/11/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Travel and Lodging | Cash or cash equivalent | $37.70 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 12/09/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,085.00 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 12/05/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $269.86 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 12/03/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: CNS | ||||||
| 10/15/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $800.89 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 10/15/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $16.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,477.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: CNS | ||||||
| 10/01/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,705.00 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 09/26/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Travel and Lodging | Cash or cash equivalent | $118.23 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 09/26/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Travel and Lodging | Cash or cash equivalent | $4.50 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 74 | 144 | $19,480 | $13,842 |
| 2020 | 3 | 133 | 336 | $38,245 | $21,580 |
Total Patients
207
Total Services
480
Medicare Billing
$35,422
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 126 | $16,600 | $11,666 | 70.3% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2021 | 17 | 18 | $2,880 | $2,176 | 75.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 245 | $28,720 | $15,498 | 54.0% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 34 | 38 | $6,080 | $3,965 | 65.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 53 | $3,445 | $2,117 | 61.4% |
About Dr. Ethan Kisch, M.D
Dr. Ethan Kisch, M.D is a Psychiatry healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063480002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ethan Kisch, M.D has received a total of $74,541 in payments from pharmaceutical and medical device companies, with $5,652 received in 2023. These payments were reported across 312 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,398).
As a Medicare-enrolled provider, Kisch has provided services to 207 Medicare beneficiaries, totaling 480 services with total Medicare billing of $35,422. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Warwick, RI
- Active Since 03/08/2006
- Last Updated 06/12/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1063480002
Products in Payments
- LATUDA (Drug) $25,274
- AUSTEDO (Drug) $20,890
- REXULTI (Drug) $7,427
- QUVIVIQ (Drug) $5,652
- VRAYLAR (Drug) $5,368
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $5,341
- SD809-TD (Drug) $892.51
- NUEDEXTA (Drug) $164.63
- ABILIFY MAINTENA (Drug) $77.62
- Adzenys XR-ODT (Drug) $55.54
- CAPLYTA (Drug) $46.91
- Trintellix (Drug) $43.31
- NeuroStar TMS Therapy (Device) $25.69
- VIIBRYD (Drug) $23.58
- MYDAYIS (Drug) $22.39
- QUILLICHEW ER (Drug) $18.69
- Cotempla XR-ODT (Drug) $18.66
- NEUROSTAR TMS THERAPY (Device) $18.06
- TRINTELLIX (Drug) $17.83
- QUILLIVANT XR (Drug) $17.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Warwick
Warren Ong, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Terrie Mailhot, Md, MD
Psychiatry — Payments: $29,075
Psychiatry $29,075
Charles Denby, Md, MD
Psychiatry — Payments: $5,968
Psychiatry $5,968
James Gallo, Md, MD
Psychiatry — Payments: $5,708
Psychiatry $5,708
David Kroessler, Md, MD
Psychiatry — Payments: $3,857
Psychiatry $3,857
Dr. Alexander Scagnelli, M.d, M.D
Psychiatry — Payments: $2,626
Psychiatry $2,626